2005 Clinical Trials Concentrates Consumption 
The Cannigma
AUGUST 14, 2022
A flow state is when all of your attention is concentrated on the task at hand, to the point that the world outside flows away. But this isn’t the only area of the brain affected by cannabis consumption. Being focused is not the same thing as being in a flow state. Focus is like a spotlight you shine on a task. Best terpenes for focus.
The Cannigma
MAY 17, 2022
A side effect of cannabis consumption is increased blood flow, particularly in the brain. Type I cannabis’ high concentration of THC can increase anxiety or drowsiness in some people, which isn’t conducive for artistic creation. So if cannabis does improve creativity for some people, how? Best terpenes for creativity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
OCTOBER 19, 2021
A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. Drunk driving, self-harm: the other risks of mixing marijuana and alcohol. arguing while drinking.
Cannabis Law Report
NOVEMBER 24, 2021
Authors of texts may use more surreptitious, and sometimes unconscious, literary devices such as rhetoric, trope, metaphor, or juxtaposition—techniques that evoke moral positions, predictions of possible effects, and prescribe solutions (Entman 1993 ; Johnson-Cartee 2005 ; Weaver 2007 ). Lanham: Rowman & Littlefield Publishers; 2005.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Medical Hypotheses (18 aug 2005).
Expert insights. Personalized for you.
118 
Let's personalize your content